 |
PDBsum entry 2vj3
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
2vj3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transcription
|
 |
|
Title:
|
 |
Human notch-1 egfs 11-13
|
|
Structure:
|
 |
Neurogenic locus notch homolog protein 1. Chain: a. Fragment: egfs 11-13, residues 411-526. Synonym: notch 1, hn1, translocation-associated notch protein tan-1, notch-1. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.60Å
|
R-factor:
|
0.239
|
R-free:
|
0.244
|
|
|
Authors:
|
 |
S.Johnson,J.Cordle,J.Z.Tay,P.Roversi,S.M.Lea
|
Key ref:
|
 |
J.Cordle
et al.
(2008).
A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibition.
Nat Struct Biol,
15,
849-857.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
06-Dec-07
|
Release date:
|
29-Jul-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P46531
(NOTC1_HUMAN) -
Neurogenic locus notch homolog protein 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
2555 a.a.
120 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 3 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Biol
15:849-857
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibition.
|
|
J.Cordle,
S.Johnson,
J.Z.Tay,
P.Roversi,
M.B.Wilkin,
B.H.de Madrid,
H.Shimizu,
S.Jensen,
P.Whiteman,
B.Jin,
C.Redfield,
M.Baron,
S.M.Lea,
P.A.Handford.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The Notch receptor and its ligands are key components in a core metazoan
signaling pathway that regulates the spatial patterning, timing and outcome of
many cell-fate decisions. Ligands contain a disulfide-rich Delta/Serrate/LAG-2
(DSL) domain required for Notch trans-activation or cis-inhibition. Here we
report the X-ray structure of a receptor binding region of a Notch ligand, the
DSL-EGF3 domains of human Jagged-1 (J-1(DSL-EGF3)). The structure reveals a
highly conserved face of the DSL domain, and we show, by functional analysis of
Drosophila melanogster ligand mutants, that this surface is required for both
cis- and trans-regulatory interactions with Notch. We also identify, using NMR,
a surface of Notch-1 involved in J-1(DSL-EGF3) binding. Our data imply that cis-
and trans-regulation may occur through the formation of structurally distinct
complexes that, unexpectedly, involve the same surfaces on both ligand and
receptor.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
(a) The overall structure of J-1[DSL-EGF3] is shown in a
cartoon representation colored from blue at the N terminus
(residue 187) to red at the C terminus (residue 335). Disulfide
bonds are shown in yellow stick representations, and two views
differing by a rotation of 90° about the long axis are
shown. (b) Stereo view of the DSL domain fold. (c) Sequences of
the four J-1[DSL-EGF3] domains with disulfide bond pairings
indicated. (d) Crystallographic structure of N-1[11–13] shown
as in a. The bound Ca^2+ in each EGF domain is shown in a
space-filling representation. All structural figures were
generated with PyMol (http://www.pymol.org/).
|
 |
Figure 3.
Analysis of an alignment of the Jagged/Delta family DSL
domains representing various species (H. sapiens Jagged-1,
residues 187–229; D. melanogaster Serrate, residues 237–279;
H. sapiens Jagged-2, residues 198–240; H. sapiens Delta-like
1, residues 179–221; D. melanogaster Delta, residues
184–226; H. sapiens Delta-like 4, residues 175–217; C.
elegans LAG-2, residues 124–166; H. sapiens Delta-like 3,
residues 178–215) (a) and the DSL structure (b) reveals a
series of highly conserved, but surface-exposed, residues.
Residues that are conserved and predicted to form a Notch
binding face are shown in red, cysteines in yellow and a
nonconserved residue on the opposite face in blue. (c)
Electrostatic surface potential of J-1[DSL-EGF3] and
N-1[11–13] plotted at 4
kT e^-1 using APBS^54. Note the positively charged patch (blue)
within the DSL domain of Jagged-1 and the negatively charged
surface (red) of Notch. The surfaces predicted by
sequence/structure analysis (J-1[DSL-EGF3]) and NMR studies
(N-1[11–13]) to be involved in binding are highlighted by
green bands.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
Nat Struct Biol
(2008,
15,
849-857)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.Sánchez-Solana,
M.L.Nueda,
M.D.Ruvira,
M.J.Ruiz-Hidalgo,
E.M.Monsalve,
S.Rivero,
J.J.García-Ramírez,
M.J.Díaz-Guerra,
V.Baladrón,
and
J.Laborda
(2011).
The EGF-like proteins DLK1 and DLK2 function as inhibitory non-canonical ligands of NOTCH1 receptor that modulate each other's activities.
|
| |
Biochim Biophys Acta,
1813,
1153-1164.
|
 |
|
|
|
|
 |
D.del Álamo,
H.Rouault,
and
F.Schweisguth
(2011).
Mechanism and significance of cis-inhibition in Notch signalling.
|
| |
Curr Biol,
21,
R40-R47.
|
 |
|
|
|
|
 |
S.Guo,
M.Liu,
and
R.R.Gonzalez-Perez
(2011).
Role of Notch and its oncogenic signaling crosstalk in breast cancer.
|
| |
Biochim Biophys Acta,
1815,
197-213.
|
 |
|
|
|
|
 |
D.Sprinzak,
A.Lakhanpal,
L.Lebon,
L.A.Santat,
M.E.Fontes,
G.A.Anderson,
J.Garcia-Ojalvo,
and
M.B.Elowitz
(2010).
Cis-interactions between Notch and Delta generate mutually exclusive signalling states.
|
| |
Nature,
465,
86-90.
|
 |
|
|
|
|
 |
I.Becam,
U.M.Fiuza,
A.M.Arias,
and
M.Milán
(2010).
A role of receptor Notch in ligand cis-inhibition in Drosophila.
|
| |
Curr Biol,
20,
554-560.
|
 |
|
|
|
|
 |
I.Dikic,
and
M.H.Schmidt
(2010).
Notch: Implications of endogenous inhibitors for therapy.
|
| |
Bioessays,
32,
481-487.
|
 |
|
|
|
|
 |
J.S.Yuan,
P.C.Kousis,
S.Suliman,
I.Visan,
and
C.J.Guidos
(2010).
Functions of notch signaling in the immune system: consensus and controversies.
|
| |
Annu Rev Immunol,
28,
343-365.
|
 |
|
|
|
|
 |
L.Haklai-Topper,
G.Mlechkovich,
D.Savariego,
I.Gokhman,
and
A.Yaron
(2010).
Cis interaction between Semaphorin6A and Plexin-A4 modulates the repulsive response to Sema6A.
|
| |
EMBO J,
29,
2635-2645.
|
 |
|
|
|
|
 |
R.C.Bauer,
A.O.Laney,
R.Smith,
J.Gerfen,
J.J.Morrissette,
S.Woyciechowski,
J.Garbarini,
K.M.Loomes,
I.D.Krantz,
Z.Urban,
B.D.Gelb,
E.Goldmuntz,
and
N.B.Spinner
(2010).
Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis.
|
| |
Hum Mutat,
31,
594-601.
|
 |
|
|
|
|
 |
R.J.Johnston,
and
C.Desplan
(2010).
Stochastic mechanisms of cell fate specification that yield random or robust outcomes.
|
| |
Annu Rev Cell Dev Biol,
26,
689-719.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2010).
Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'.
|
| |
J Mol Recognit,
23,
1.
|
 |
|
|
|
|
 |
U.M.Fiuza,
T.Klein,
A.Martinez Arias,
and
P.Hayward
(2010).
Mechanisms of ligand-mediated inhibition in Notch signaling activity in Drosophila.
|
| |
Dev Dyn,
239,
798-805.
|
 |
|
|
|
|
 |
A.C.Miller,
E.L.Lyons,
and
T.G.Herman
(2009).
cis-Inhibition of Notch by endogenous Delta biases the outcome of lateral inhibition.
|
| |
Curr Biol,
19,
1378-1383.
|
 |
|
|
|
|
 |
A.Pintar,
C.Guarnaccia,
S.Dhir,
and
S.Pongor
(2009).
Exon 6 of human JAG1 encodes a conserved structural unit.
|
| |
BMC Struct Biol,
9,
43.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Guarnaccia,
S.Dhir,
A.Pintar,
and
S.Pongor
(2009).
The tetralogy of Fallot-associated G274D mutation impairs folding of the second epidermal growth factor repeat in Jagged-1.
|
| |
FEBS J,
276,
6247-6257.
|
 |
|
|
|
|
 |
C.Opherk,
M.Duering,
N.Peters,
A.Karpinska,
S.Rosner,
E.Schneider,
B.Bader,
A.Giese,
and
M.Dichgans
(2009).
CADASIL mutations enhance spontaneous multimerization of NOTCH3.
|
| |
Hum Mol Genet,
18,
2761-2767.
|
 |
|
|
|
|
 |
D.del Alamo,
and
F.Schweisguth
(2009).
Notch signalling: receptor cis-inhibition to achieve directionality.
|
| |
Curr Biol,
19,
R683-R684.
|
 |
|
|
|
|
 |
K.B.Luther,
and
R.S.Haltiwanger
(2009).
Role of unusual O-glycans in intercellular signaling.
|
| |
Int J Biochem Cell Biol,
41,
1011-1024.
|
 |
|
|
|
|
 |
R.Kopan,
and
M.X.Ilagan
(2009).
The canonical Notch signaling pathway: unfolding the activation mechanism.
|
| |
Cell,
137,
216-233.
|
 |
|
|
|
|
 |
S.A.Jensen,
S.Iqbal,
E.D.Lowe,
C.Redfield,
and
P.A.Handford
(2009).
Structure and interdomain interactions of a hybrid domain: a disulphide-rich module of the fibrillin/LTBP superfamily of matrix proteins.
|
| |
Structure,
17,
759-768.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.L.Dunwoodie
(2009).
The role of Notch in patterning the human vertebral column.
|
| |
Curr Opin Genet Dev,
19,
329-337.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |